Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Canada warns on ephedra, kava

This article was originally published in The Tan Sheet

Executive Summary

Health Canada advises Aug. 21 that two unauthorized natural health products with ephedrine and kava could cause "serious adverse health effects including death." Life Choice Ephedrine HCL "contains an excessive amount of ephedrine," which may react adversely to caffeine or other stimulants, and has been found to be contaminated with bacteria, the agency reports in a same-day release. Health Canada recalled certain ephedra products in 2002 and currently advises their use only for nasal decongestion (1"The Tan Sheet" June 16, 2003, In Brief). Consumers should also discontinue use of Life Choice Kava Kava, the agency says, due to concerns of liver toxicity related to consumption of kava products. Health Canada halted Kava product sales in August 2002 and they are also banned in the U.K. (2"The Tan Sheet" Aug. 26, 2002, In Brief and 3"The Tan Sheet" Aug. 7, 2006, In Brief)

You may also be interested in...

Canada on ephedra

Recalled ephedra items are still available "under the counter, in back rooms and at gyms," agency states in June 9 1advisory asking consumers to report such activities. Health Canada recalled certain ephedra products last year (2"The Tan Sheet" Jan. 14, 2002, p. 16)...

Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts

Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.

Back With A Bang: ‘Brexit Bill’ For UK’s Medical Devices Due For 2nd Reading On 2 March

Parliamentary debate next week on the post-Brexit regulatory adjustments ahead for the UK medical devices industry will coincide with the opening of post-Brexit EU trade talks by the UK government. After a period of nervous calm, Brexit will be back with a bang.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts